Nexavar impresses in clinical trials

[News]

Patients who received Nexavar along with the chemo drug Xeloda had a 74 percent improvement in the amount of time they lived without a disease progression, researchers found.

More... (http://www.healthcentral.com/breast-cancer/news-376622-98.html)